N-[4-[7-chloro-5-[3-(4-methylpiperazin-1-yl)propylamino]-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]-3-methyl-phenyl]-2-methyl-benzamide

ID: ALA5180200

Chembl Id: CHEMBL5180200

PubChem CID: 167183380

Max Phase: Preclinical

Molecular Formula: C34H42ClN5O2

Molecular Weight: 588.20

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(NCCCN3CCN(C)CC3)c3cc(Cl)ccc32)c(C)c1

Standard InChI:  InChI=1S/C34H42ClN5O2/c1-24-8-4-5-9-28(24)33(41)37-27-12-13-29(25(2)22-27)34(42)40-17-6-10-31(30-23-26(35)11-14-32(30)40)36-15-7-16-39-20-18-38(3)19-21-39/h4-5,8-9,11-14,22-23,31,36H,6-7,10,15-21H2,1-3H3,(H,37,41)

Standard InChI Key:  UJCAELQBXPGPSA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5180200

    ---

Associated Targets(Human)

AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 588.20Molecular Weight (Monoisotopic): 587.3027AlogP: 5.92#Rotatable Bonds: 8
Polar Surface Area: 67.92Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.03CX LogP: 5.60CX LogD: 3.46
Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.32Np Likeness Score: -1.58

References

1. Zhang H, Yan W, Sun Y, Yuan H, Su L, Cao X, Wang P, Xu Z, Hu Y, Wang Z, Wang Y, Fu K, Sun Y, Chen Y, Cheng J, Guo D..  (2022)  Long Residence Time at the Vasopressin V2 Receptor Translates into Superior Inhibitory Effects in Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney Disease.,  65  (11.0): [PMID:35363466] [10.1021/acs.jmedchem.2c00011]

Source